NCT02230891View on ClinicalTrials.gov

Biomarker Guided Therapies in Stage A/B Heart Failure

PHASE2CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

October 1, 2014

Primary Completion Date

December 15, 2020

Study Completion Date

December 15, 2020

Conditions
HypertensionDiabetesCardiovascular Disease
Interventions
DRUG

Carvedilol

Carvedilol is a non selective beta blocker

DRUG

Spironolactone

Spironolactone is an aldosterone antagonist and can lower blood pressure/ is used in heart failure

OTHER

Usual care

standard care as per primary care provider

Trial Locations (1)

77030

Michael E. DeBakey VA Medical Center, Houston, TX, Houston

All Listed Sponsors
collaborator

Baylor College of Medicine

OTHER

lead

VA Office of Research and Development

FED

NCT02230891 - Biomarker Guided Therapies in Stage A/B Heart Failure | Biotech Hunter | Biotech Hunter